An updated analysis of JULIET, a global pivotal phase 2 trial of tisagenlecleucel in adult patients with relapsed or refractory (r/r) diffuse large B-cell lymphoma (DLBCL) Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Borchmann, P
  • Tam, CS
  • Jaeger, U
  • McGuirk, JP
  • Holte, H
  • Waller, EK
  • Jaglowski, SM
  • Bishop, MR
  • Andreadis, C
  • Foley, Ronan
  • Westin, JR
  • Fleury, I
  • Ho, PJ
  • Mielke, S
  • Salles, G
  • Maziarz, RT
  • Anak, Oe
  • Pacaud, LB
  • del Corral, C
  • Awasthi, R
  • Agoulnik, S
  • Tai, F
  • Schuster, SJ

publication date

  • January 1, 2018